Poxvirus vector encoding prostate specific antigens for treatment of prostate cancer

Details for Australian Patent Application No. 2011201813 (hide)

Owner Virax Development Pty Ltd

Inventors Howley, Paul Michael; Brown, Michael Paul

Agent Davies Collison Cave

Pub. Number AU-A-2011201813

Parent 2004267117

Filing date 20 April 2011

Wipo publication date 19 May 2011

International Classifications

C12N 15/863 (2006.01) Mutation or genetic engineering - Poxviral vectors, e.g. vaccinia virus

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 9/16 (2006.01) Enzymes, e.g. ligases (6.) - acting on ester bonds (3.1)

C12N 15/12 (2006.01) Mutation or genetic engineering - Genes encoding animal proteins

Event Publications

12 May 2011 Complete Application Filed

19 May 2011 Application Open to Public Inspection

  Published as AU-A-2011201813

15 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011201814-Flavour capsule for enhanced flavour delivery in cigarettes

2011201812-Systems employing a push tube for de- livering a urethral sling